Improving the Treatment of Mood and Anxiety Disorders - November 14, 2014

Improving the Treatment of Mood and Anxiety Disorders - November 14, 2014

When Nov 14, 2014
from 08:00 AM to 04:30 PM
Where The Clifton Center, 2117 Payne Street, Louisville, KY 40206
Add event to calendarvCal

*Agenda *Brochure *CE Credit *Course Director & Faculty *Registration

Course Description
This conference is aimed at deepening participant’s knowledge of the causes, course, and most effective treatments for commonly occurring mood and anxiety disorders. There will be a special focus on building skills for enhancing the resilience of patients, applying the most useful psychopharmacologic strategies in challenging treatment situations, and relieving psychological distress that women encounter during the life cycle. Participants will have the opportunity to learn from leading experts in biological and psychosocial treatment approaches.

Target Audience
The target audience for this seminar is psychiatrists, psychologists, social workers, nurses, primary care practitioners, and other mental health professionals.


Improving the Treatment of Mood and Anxiety Disorders - November 14, 2014

Friday, November 14, 2014
Morning Session:
8:15 AM
Registration and Continental Breakfast

8:40 AM

8:50 AM
Advances in the Psychopharmacology of Depression: Stubborn Challenges, Promising Leads
Jonathan Alpert MD, PhD

9:40 AM

10:00 AM
The Context of a Woman’s Life: Does it Affect the Treatment of Her Depression?
Joyce Spurgeon MD

10:50 AM
Roadmap to Resilience: Helping Patients Cope with Trauma
Donald Meichenbaum, PhD

11:40 AM
Panel Discussion
Drs. Alpert, Spurgeon, and Meichenbaum


Afternoon Session:
1:00 PM
Workshop I: 1:00-2:30 PM
(1) Better But Not Well: On the Psychopharmacology of Residual Symptoms
Jonathan E. Alpert, MD, PhD
(2) Cognitive-behavioral Treatment Strategies for Individuals with PTSD and Prolonged and Complicated Grief
Donald Meichenbaum, PhD
(3) Treating Anxiety Disorders in Children and Adolescents
John E. Gallehr, MD

2:30 PM

2:50 PM
Workshop II: 2:50-4:20 PM
(1) Wellbeing Therapy: From Symptom Relief to Personal Growth
Jesse H. Wright, MD, PhD
(2) Building Skills in Treating Generalized Anxiety Disorder
Amanda B. Hettinger, MD
(3) Women and Substance Use Disorders: Update on Trends and Treatment Options
Jonathan W. Weeks, MD and Joyce Spurgeon, MD

4:20 PM
Course Evaluation

4:30 PM
Conference Adjourns

Course Director
Jesse H. Wright, MD, PhD

Professor and Vice-Chair for Academic Affairs
University of Louisville Department of Psychiatry and Behavioral Sciences
University of Louisville Depression Center
Louisville, Kentucky

Participating Faculty:
Jonathan E. Alpert, MD, PhD
Joyce R. Tedlow Chair in Depression Studies
Harvard Medical School
Associate Chief and Clinical Director
Department of Psychiatry, Massachusetts General Hospital
MGH Depression Clinical and Research Program
Boston, Massachusetts

John E. Gallehr, MD
Assistant Professor
University of Louisville Department of Pediatrics, Division of Child and Adolescent Psychiatry and Psychology
Louisville, Kentucky

Amanda B. Hettinger, MD
Assistant Professor
Associate Director
Residency Training Program
University of Louisville Department of Psychiatry and Behavioral Sciences
Louisville, Kentucky

Sarah B. Johnson, MD, MSc
Assistant Professor
University of Louisville Hospital Inpatient Psychiatric Services
Medical Student Education
University of Louisville Department of Psychiatry and Behavioral Sciences
Louisville, Kentucky

Donald Meichenbaum, PhD
Distinguished Professor Emeritus
University of Waterloo
Ontario, Canada
Research Director
Melissa Institute for Violence Prevention and Treatment of Victims of Violence
Miami, Florida

Joyce A. Spurgeon, MD
Associate Professor and Director
Residency Training Program
University of Louisville Department of Psychiatry and Behavioral Sciences
Louisville, Kentucky

Jonathan W. Weeks, MD    
Associate Professor
University of Louisville Department of Obstetrics, Gynecology and Women’s Health, Maternal-Fetal Medicine
Louisville, Kentucky

Learning Objectives:

As a result of participating in this activity, participants should be able to:

1. Recognize factors that impede response to antidepressants and identify approaches to next-step treatments.
2. Discuss pharmacological advances, including promising targets for novel medications, for addressing residual symptoms in key disorders including anxiety, bipolar disorder, depression, and schizophrenia.
3. Utilize an understanding of sociocultural, biological, and psychological contexts to enhance treatment of depression in women.
4. Identify factors that contribute to the development of PTSD and comorbid disorders in trauma-exposed individuals and compare these with characteristics of persons who develop resilience, and in some instances, post-traumatic growth.
5. Implement specific strategies to help patients bolster their resilience.
6. Detail methods from wellbeing therapy that can help patients overcome treatment resistance and promote personal growth.
7. Identify effective psychotherapeutic and psychopharmacologic interventions for generalized anxiety disorder.
8. Recognize key methods for evidence-based treatment of anxiety disorders in children and adolescents.
9. Identify current treatment methods for women with substance abuse disorders.

Continuing Education Credit
Physician Credit
- The University of Louisville Continuing Medical Education office designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses - This program has been approved by the Kentucky Board of Nursing for 7.2 continuing education credits through University of Louisville Hospital, provider number 4-0068-7-16-830. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content.

Social Workers - The Kentucky Board of Social Work has approved this course for 6.0 credits provider number KBSW2014085

The University of Louisville School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Special Services
All individuals are encouraged to participate. To request disability arrangements, please contact the Improving the Treatment of Mood and Anxiety Disorders Administrative Coordinator, Carol Wahl, at (502) 813-6634 at least 14 days prior to the date of this program. Continuing Medical Education and Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.


Click Here for a copy of the course brochure (Under Construction)

Registration Fees:

UofL Physicians                                          $  0
UofL Nurses                                                 $  0
All Other Non-physician UofL Faculty       $  0
UofL Students                                              $  0                  
UofL Residents                                            $  0

Physicians                                                 $ 100                   
Nurses                                                        $ 100                  
All Other Healthcare Professionals         $ 100

Note: 10 scholarships have been made available for each co-sponsor. Please contact Carol Wahl to determine your eligibility.

Online Registration for this event is now closed. You may still attend the conference by registering the morning of the program at the registration desk on November 14, 2014 beginning at 8:15 AM at The Clifton Center, 2117 Payne Street, Louisville, KY 40206.

Refund Policy
Requests for cancellation must be submitted to on or before Friday, October 31, 2014. Requests received on or before Friday, October 31, 2014 will receive a full refund less a $25 processing fee. No refund will be given for requests received after Friday, October 31, 2014.


We thank our supporting and exhibiting companies for their participation in the Improving the Treatment of Mood and Anxiety Disorders 2014 conference!

A final listing of supporters and exhibitors will be available at the meeting.